Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79.8M
-
Number of holders
-
83
-
Total 13F shares, excl. options
-
20.5M
-
Shares change
-
+120K
-
Total reported value, excl. options
-
$129M
-
Value change
-
-$1.07M
-
Put/Call ratio
-
0.53
-
Number of buys
-
34
-
Number of sells
-
-44
-
Price
-
$6.27
Significant Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q3 2021
112 filings reported holding NAGE - Niagen Bioscience, Inc. - Common Stock as of Q3 2021.
Niagen Bioscience, Inc. - Common Stock (NAGE) has 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20.5M shares
of 79.8M outstanding shares and own 25.7% of the company stock.
Largest 10 shareholders include Yong Rong (HK) Asset Management Ltd (4.13M shares), BlackRock Inc. (3.14M shares), VANGUARD GROUP INC (2.63M shares), BANK OF AMERICA CORP /DE/ (1.43M shares), ICONIQ Capital, LLC (1.3M shares), BARCLAYS PLC (957K shares), STATE STREET CORP (885K shares), GEODE CAPITAL MANAGEMENT, LLC (864K shares), Nuveen Asset Management, LLC (782K shares), and Uniplan Investment Counsel, Inc. (681K shares).
This table shows the top 83 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.